Patent details

Basic Information

Publication number:

EP3206682

PCT Application Number:

IB2015057870

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157849746

PCT Publication Number:

WO2016059571

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

French Title of Invention:

COMBINAISONS COMPRENANT DU SIPONIMOD ET DU LAQUINIMOD POUR LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES

German Title of Invention:

KOMBINATIONEN ENTHALTEND SIPONIMOD UND LAQUINIMOD ZUR BEHANDLUNG DER MULTIPLEN SKLEROSE

SPC Number:

Dates

Filing date:

14/10/2015

Grant date:

26/09/2018

EP Publication Date:

23/08/2017

PCT Publication Date:

21/04/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/09/2018

EP B1 Publication Date:

26/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/10/2018

Expiration date:

14/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/09/2018

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

SMITH, Paul Alfred

Address:

Switzerland (CH)

Priority

Priority Number:

201462064537 P

Priority Date:

16/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/397; A61K 31/4704; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

201839

Publication date:

26/09/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1